Akero Therapeutics, Inc.

GOLDMAN SACHS GROUP INC AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

855,766

Value ($000)

40,632

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	40,632	0.0%	855,766	9/30/2025
2025 Q2	8/14/2025	40,860	0.0%	765,741	6/30/2025
2025 Q1	6/27/2025	19,770	0.0%	488,392	3/31/2025
2024 Q4	2/11/2025	12,728	0.0%	457,524	12/31/2024
2024 Q3	11/14/2024	19,002	0.0%	662,321	9/30/2024
2024 Q2	8/13/2024	18,368	0.0%	782,950	6/30/2024
2024 Q1	5/15/2024	14,900	0.0%	589,852	3/31/2024
2023 Q4	5/14/2024	14,339	0.0%	613,275	12/31/2023
2023 Q3	5/15/2024	31,236	0.0%	331,085	9/30/2023
2023 Q2	5/14/2024	9,760	0.0%	209,043	6/30/2023
2023 Q1	5/14/2024	8,543	0.0%	223,291	3/31/2023
2022 Q4	5/14/2024	10,188	0.0%	185,912	12/31/2022
2022 Q3	5/14/2024	72,145	0.0%	2,118,797	9/30/2022
2022 Q2	5/14/2024	0	0.0%	1,863,604	6/30/2022
2022 Q1	5/16/2022	15,505	0.0%	1,092,680	3/31/2022
2021 Q4	2/17/2022	37,366	0.0%	1,766,714	12/31/2021
2021 Q3	1/20/2022	697	0.0%	31,184	9/30/2021
2021 Q2	8/13/2021	709	0.0%	28,574	6/30/2021
2021 Q1	5/17/2021	6,076	0.0%	209,427	3/31/2021
2020 Q4	2/12/2021	6,442	0.0%	249,705	12/31/2020
2020 Q3	11/13/2020	1,902	0.0%	61,758	9/30/2020
2020 Q2	8/12/2020	1,764	0.0%	70,771	6/30/2020
2020 Q1	5/15/2020	1,159	0.0%	54,663	3/31/2020
2019 Q4	2/14/2020	819	0.0%	36,886	12/31/2019